期刊
JOURNAL OF CLINICAL IMMUNOLOGY
卷 41, 期 2, 页码 324-334出版社
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10875-020-00925-0
关键词
COVID-19; coronavirus; influenza; vaccine; healthcare workers; case– control
类别
The study found that the 2019 influenza vaccine may have a protective association against COVID-19 among healthcare workers, with data showing a lower probability of contracting COVID-19 among individuals who received the influenza vaccine.
Purpose The influenza vaccine is essential in reducing the influenza burden, especially among healthcare workers (HCW). Experimental studies suggest both coronaviruses and influenza viruses engage with the angiotensin-converting enzyme 2 (ACE 2) and tetraspanin antibodies, and that ACE 2 tetraspanin antibodies in turn may inhibit both coronavirus and low-pathogenicity influenza A viruses (LP IAV) infections. This study aims to investigate the potential clinical association between receiving the 2019 influenza vaccine and the incidence of COVID-19 among HCW. Methods We designed a case-control study within a hospital setting in Iran when it became a center for treating COVID-19 patients. We collected data and calculated relevant incidence and associative measures among HCW who had received the 2019 influenza vaccine as compared to HCW who had not received the vaccine. Results Our total sample size was 261 HCW. Of 80 COVID-19 incident cases, three cases had received the influenza vaccine, while 87 of 181 controls had received the vaccine. The odds ratio (OR) and confidence interval (CI) of being vaccinated were 0.04 (95% CI: 0.01 to 0.14) among COVID-19 cases as compared to controls. Conclusions Significant findings suggest that the 2019 influenza vaccine may have a protective association against COVID-19 among HCW.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据